Latest filing published 20 Dec 2022 for Profound Medical Corp. (formerly Mira IV Acquisition Corp.), €70k.
This profile gathers the share dealings of Menawat, Dr., Arun in Profound Medical Corp. (formerly Mira IV Acquisition Corp.). We count 24 filings; the first trade dates from 4 June 2015 and the latest from 20 December 2022.
Every open-market trade on record is a purchase: 17 purchases worth €1.1M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 option exercises. So far in 2022, the count stands at 7 purchases and no sales.
The median purchase comes to €39k. No cluster: in 16 purchases, no other insider of the company bought within 30 days.
The latest filing, published on 20 December 2022, reports an open-market purchase of €70k in Profound Medical Corp. (formerly Mira IV Acquisition Corp.). Between a trade and the moment it shows up on SEDI, the median delay is 1 day. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations